List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 117 studies with search of:   "primary pulmonary hypertension"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Conditions: Primary Myelofibrosis;   Primary Pulmonary Hypertension;   Secondary Myelofibrosis;   Pulmonary Arterial Hypertension
Intervention:
2 Recruiting Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Other: No specific intervention;   Other: No specific intervention
3 Recruiting Pharmacogenomics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Sitaxsentan;   Drug: Bosentan, Ambrisentan
4 Recruiting The Early Recognition of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Device: ETED, CPET, RHC
5 Terminated Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Iloprost Inhalation Solution (Ventavis)
6 Recruiting Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: iloprost power 15 ( Ventavis(R));   Drug: placebo
7 Enrolling by invitation Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: iloprost;   Drug: iloprost
8 Enrolling by invitation Long-Term Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: ACT-064992
9 Recruiting 6R-BH4 Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sapropterin dihydrochloride
10 Recruiting Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Interventions: Drug: sildenafil;   Drug: sildenafil
11 Recruiting Study of ACT-064992 on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-064992;   Drug: ACT-064992;   Drug: Placebo
12 Recruiting Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: iloprost
13 Terminated Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Remodulin (treprostinil sodium)
14 Active, not recruiting Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sorafenib
15 Recruiting Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: GSK1325760A
16 Active, not recruiting Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Imatinib mesylate;   Drug: Placebo
17 Completed Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
Condition: Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
Intervention: Drug: bosentan
18 Completed A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Intervention: Drug: treprostinil sodium
19 Recruiting Pulmonary Arterial Hypertension in Systemic Sclerosis
Conditions: Systemic Sclerosis;   Pulmonary Arterial Hypertension
Intervention:
20 Active, not recruiting A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
Conditions: PAH;   Pulmonary Arterial Hypertension
Intervention: Drug: Sitaxsentan

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services